GLP-1 Stimulating Fiber Approved for Food Use: Unlocking Health Benefits

Supercharged Fiber Products

Innovative Fiber-Enriched Products: Breads and Smoothies on the Horizon

Credit: Panther Media Global / Alamy

Breads, smoothies, and cereals containing ‘supercharged’ fiber might hit the European market in the next year. This specialized fiber enhances the release of appetite-regulating hormones like GLP-1, which aids in preventing weight gain. The fiber has been approved as safe for consumption by the European Food Safety Authority.

“Randomized controlled trials involving middle-aged individuals demonstrated that daily intake helps protect against weight gain,” says Gary Frost from Imperial College London. “While we didn’t observe weight impact in younger subjects, there was a notable improvement in body composition, resulting in increased lean body mass.”

Dietary fiber consists of indigestible molecules, yet certain gut bacteria can process them. This breakdown produces short-chain fatty acids, which stimulate the release of appetite-reducing hormones such as PYY and GLP-1—effects similar to those seen with weight loss medications like Ozempic.

However, to achieve these benefits, a significant fiber intake is necessary. Animal research indicates about 80 grams of fiber is required to trigger adequate short-chain fatty acid production for hormonal release, according to Douglas Morrison from the University of Glasgow, UK. Although most recommendations suggest consuming a minimum of 25 to 30 grams of fiber daily, many people fall short.

Remarkably, even just 10 grams a day of a potent fiber known as inulin propionate (IPE) can yield this desired effect. In a randomized control study involving 60 overweight participants aged 40-65, Frost, Morrison, and their team demonstrated that blood levels of GLP-1 and PYY rose after 10 grams of IPE was consumed, leading to decreased food intake. Over six months, none of the IPE recipients experienced significant weight gain, whereas 17% in the control group did. A minor side effect observed was increased bloating, common with high-fiber diets.

In another randomized control trial involving 270 overweight individuals aged 20-40, there was no marked weight difference after one year between those who consumed IPE and those who did not. However, IPE consumers saw an average gain of over 1 kilogram in lean body mass.

IPE was developed 15 years ago by Frost while researching the effects of short-chain fatty acids on the large intestine. Direct consumption was not feasible due to its unpleasant taste and pre-absorption in the small intestine. “Methods to introduce it orally or rectally are uncomfortable,” notes Morrison.

To counteract this, Morrison synthesized IPE by combining propionate with inulin, a widely used fiber supplement derived from several plants.

Once ingested, IPE passes through the stomach and small intestine, where gut bacteria break it down. The liberated inulin acts as regular fiber, while the released propionate boosts short-chain fatty acid levels sufficient to trigger GLP-1 and PYY release. “[The propionate is pivotal in addressing fiber consumption issues,” Morrison adds.

After 12 years of research, Frost, Morrison, and their team finally secured approval from the European Food Safety Authority. “Few academic teams have transitioned research from the lab to a viable food product,” Frost states.

This approval is valid in the European Union, with expectations for UK regulators to follow shortly. Frost and Morrison are in discussions with companies to launch IPE-infused products like smoothies, cereals, and breads. “I anticipate IPE will debut on the EU market within a year,” Morrison predicts. While most individuals do not detect added IPE, a small minority may perceive it as bitter.

However, Brendan Gabriel, a researcher at the University of Aberdeen, UK, questions the strength of evidence supporting IPE’s benefits. The initial trial demonstrating its effectiveness in weight maintenance for those over 40 involved limited participants, whereas the trial highlighting lean mass increase in younger individuals lacked clarity on whether the growth was muscular or comprised other non-fat tissues. He emphasizes, “Nonetheless, incorporating fiber into a nutritious diet or through IPE supplements may provide various health advantages and promote gut health.”

Professor Frost expressed interest in further research, particularly regarding IPE’s role in maintaining lean body mass when using GLP-1 medications and its potential to minimize weight gain upon medication cessation.

Topics:

This rewrite optimizes for relevant keywords while maintaining the integrity of the HTML tags and structure.

Source: www.newscientist.com

Electrically Stimulating the Brain Makes Hypnotism More Accessible

Hypnosis may involve a therapist bringing a patient into a deeply relaxed state to treat symptoms or change habits.

Voisin/Fanny/Science Photo Library

Sending electrical pulses to certain parts of the brain can make people more susceptible to hypnosis. Although the research is still in its early stages, it could eventually lead to more widespread use of hypnotherapy for conditions such as chronic pain.

“There are a lot of different ways to treat different disorders and symptoms, both in psychology and psychiatry,” he says. Afik Furman at Stanford University in California. “Hypnosis is one psychological technique that has been proven to be effective for anxiety, depression, and especially pain.”

Previous research suggests that People who are highly susceptible to hypnosis have better connections between the two parts of their brains. Left dorsolateral prefrontal cortex and dorsal anterior cingulate cortex.They also suggest that Stimulating the former area strengthens this connection.

Faerman and colleagues focused on the dorsolateral prefrontal cortex, located at the front of the brain, and administered transcranial magnetic stimulation to 40 people with the chronic pain condition fibromyalgia. This was administered as 800 pulses to the scalp via a paddle, and the procedure lasted just over 1.5 minutes. This method uses a magnetic field to stimulate nerve cells in the target tissue.

Another 40 people with the same symptoms were given the sham treatment. At the start of the study, none of the participants were thought to be susceptible to hypnosis.

Hypnotherapy is generally defined as the use of hypnosis to treat symptoms or change habits. Susceptibility to hypnosis was assessed by the “hypnoinduction profile,” a standard method for measuring hypnotic efficacy.

After just one session, the group that received electrical brain stimulation had increased hypnotic susceptibility for up to an hour, while the other groups showed no change.

The researchers did not measure whether fibromyalgia symptoms improved in either group. “Our main goal was to figure out whether it was possible to alter the hypnotic state, so we were really excited to be able to do that,” say team members. nolan williams at Stanford University.

Researchers now hope to repeat the study with more people with more diverse symptoms. They also want to see whether fine-tuning the length or number of electrical stimulation pulses a person receives affects hypnotic susceptibility.

Despite showing some promise as a medical use, hypnotherapy is not routinely covered by health insurance companies in the United States or the National Health Service in the United Kingdom.

topic:

Source: www.newscientist.com